Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|28|3|244-251

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.28, Iss.3, 2009-09, pp. : 244-251

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of the Effect of Memantine in Reducing the Worsening of Clinical Symptoms in Patients with Moderate to Severe Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 2, 2007-07 ,pp. : 138-145

Karger

Access to resources Recommend Favorite

Donepezil for the Treatment of Mild to Moderate Alzheimer’s Disease in France: The Economic Implications

By  

Dementia and Geriatric Cognitive Disorders, Vol. 17, Iss. 1-2, 2003-12 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

An Economic Evaluation of Donepezil in Mild to Moderate Alzheimer’s Disease: Results of a 1-Year, Double-Blind, Randomized Trial

By  

Dementia and Geriatric Cognitive Disorders, Vol. 15, Iss. 1, 2002-12 ,pp. : 44-54

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 299-313

Karger

Access to resources Recommend Favorite

Economic Analysis of Galantamine, a Cholinesterase Inhibitor, in the Treatment of Patients with Mild to Moderate Alzheimer’s Disease in The Netherlands

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 2, 2002-07 ,pp. : 84-89

Karger

Access to resources Recommend Favorite